文献速递慢性静脉疾病

症状性静脉结扎的血管内再通与支架重建:技术与结局

Techniques and Outcomes of Recanalization and Reconstruction for Treatment of Symptomatic Venous Ligation.
PubMed 文献 · Ann Vasc Surg · 2026-02-04

单中心回顾性研究纳入9例症状性静脉结扎患者,行血管内再通与支架重建,初始单次再通率100%,主要/次要通畅率88.9%,临床改善率88.9%,无死亡,提示该技术安全有效。

要点

  • 症状性静脉结扎可行血管内再通与支架重建,初始单次再通率100%。
  • 主要/次要通畅率88.9%,临床改善率88.9%,完全症状缓解率66.7%。
  • 严重不良事件发生率10.0%(SIR D类),无死亡。

核心结论

  • 血管内再通与重建是症状性静脉结扎安全有效的治疗方法。

研究设计与样本

  • 单中心回顾性研究,纳入2014年1月至2024年1月间9例(平均年龄52.9岁)因症状性静脉结扎行血管内再通与支架重建的患者。

主要发现

  • 初始单次再通在9例患者中均成功(100%),共行10次手术,1例因早期血栓形成需再次干预。
  • 1例(11.1%)发生早期支架闭塞且无法再通,其余重建血管保持通畅(主要/次要通畅率88.9%)。
  • 平均影像随访466.4±500.3天,平均临床随访1,086.2±717.5天;主要不良事件1例(10.0%,SIR D类),轻微不良事件1例(10.0%,SIR A类)。
  • 临床改善8例(88.9%),其中完全症状缓解6例(66.7%),无死亡。

临床怎么用

  • 对于症状性静脉结扎患者,可考虑血管内再通与支架重建作为治疗选择。

局限性

  • 单中心回顾性研究,样本量小(9例),随访时间变异大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To report techniques, adverse events, and outcomes of endovascular recanalization and stent reconstruction for symptomatic venous ligation. METHODS: In this single-center retrospective study, 9 patients (mean age, 52.9), underwent endovenous recanalization and stent reconstruction for symptomatic venous ligation between January 2014 and January 2024. Patients presented with clinical-etiology-anatomy-pathophysiology 3 (55.6%), 4 (11.1%), and 5 (33.3%) disease. Ligation sites commonly involved the external iliac (66.7%) or femoral veins (44.4%); 5 patients had multisegment ligation. Etiologies included surgical injury (44.4%), trauma (22.2%), chronic venous thrombosis (22.2%), and malignant resection (11.1%). Procedural techniques, recanalization methods, stent selection, adverse events, patency, and clinical outcomes were recorded. RESULTS: Primary single-session recanalization was achieved in 9 patients (100%). Ten procedures were performed, as 1 patient required reintervention for early thrombosis. Sharp extravascular techniques were required in 6 procedures (60%). Twenty-six stents were deployed (Wallstents, cTAG devices, SMART stents), with a mean of 2.9 ± 2.5 stents per patient and mean stent diameter of 15.5 ± 3.2 mm. One patient (11.1%) developed early stent occlusion and was unable to be recanalized. All other reconstructions remained patent (primary/secondary patency 88.9%). Mean imaging follow-up was 466.4 ± 500.3 days, and mean clinical follow-up was 1,086.2 ± 717.5 days. Adverse events included 1 major (10.0%; Society of Interventional Radiology (SIR) class D) and 1 minor (10.0%; SIR class A). Clinical improvement occurred in 8 patients (88.9%), including complete symptom resolution in 6 (66.7%). No mortality occurred. CONCLUSION: Endovenous recanalization and reconstruction is a safe and effective treatment for symptomatic venous ligation.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Woerner A, Umapathy MP, Chick JFB, et al. Techniques and Outcomes of Recanalization and Reconstruction for Treatment of Symptomatic Venous Ligation. Ann Vasc Surg. 2026. PMID: 41651165. doi:10.1016/j.avsg.2026.01.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。